A detailed history of Ever Source Wealth Advisors, LLC transactions in Zai Lab LTD stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 98 shares of ZLAB stock, worth $2,824. This represents 0.0% of its overall portfolio holdings.

Number of Shares
98
Previous 95 3.16%
Holding current value
$2,824
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$24.61 - $33.18 $73 - $99
3 Added 3.16%
98 $2,000
Q3 2024

Nov 08, 2024

BUY
$16.25 - $24.14 $16 - $24
1 Added 1.06%
95 $2,000
Q2 2024

Aug 13, 2024

SELL
$13.72 - $21.55 $850 - $1,336
-62 Reduced 39.74%
94 $1,000
Q1 2024

Jun 11, 2024

BUY
$15.95 - $26.8 $2,488 - $4,180
156 New
156 $2,000
Q3 2022

Nov 07, 2022

BUY
$34.2 - $51.69 $27,702 - $41,868
810 New
810 $28,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.82B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.